Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: Clinical significance, diagnostic strategies and implications for preparticipation screening

British Journal of Sports Medicine

Volumn 43, Issue 9, 2009, Pages 649-656

  Maron, B J ^a  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

AORTA STENOSIS; ATHLETE; CONGESTIVE CARDIOMYOPATHY; CONSENSUS; CORONARY ARTERY DISEASE; CYCLING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG ABUSE; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART TUMOR; HEART VENTRICLE REMODELING; HEAT STROKE; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LUNG DISEASE; MEDICAL PRACTICE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PHENOTYPE; PHYSICAL EXAMINATION; REVIEW; ROWING; RUNNING; SARCOIDOSIS; SCREENING; SEX DIFFERENCE; SICKLE CELL ANEMIA; SKIING; SPORT; STROKE; SUDDEN DEATH; SWIMMING; TENNIS; UNITED STATES; VOLLEYBALL; WEIGHT LIFTING; WRESTLING;

CARDIOMYOPATHY, HYPERTROPHIC; COMPETITIVE BEHAVIOR; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; SPORTS;

EID: 69949142200     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsm.2008.054726     Document Type: Review

References (80)

1. Maron BJ. Sudden death in young athletes. N Engl J Med 2000;349:1064-1075
2. Maron BJ. Sudden death in young athletes: lessons from the Hank Gathers affair. N Engl J Med 1993;329:55-57
3. Maron BJ, Roberts WC, McAllister HA, et al. Sudden death in young athletes. Circulation 1980;62:218-229
4. Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:516-524
5. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-369 (Pubitemid 28363798)
6. Maron BJ. How should we screen competitive athletes for cardiovascular disease? [editorial]. Eur Heart J 2005;26:428-430
7. Maron BJ, Pelliccia A. The heart of trained athletes: Cardiac remodeling and the risks of sports including sudden death. Circulation 2006;114:1633-1644 (Pubitemid 44547434)
8. Maron BJ, Douglas PS, Graham TP, et al. Task Force 1: Preparticipation screening and diagnosis of cardiovascular disease in athletes. In 36th Bethesda Conference. Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities (Maron BJ and Zipes DP). J Am Coll Cardiol 2005;45:1322-1326 (Pubitemid 40528407)
9. Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete's heart: A clinical problem of increasing magnitude and significance. Heart 2005;91:1380-1382
10. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1,866 deaths in the US, 1980-2006. Circulation 2009;119:1085-1092
11. Maron BJ, Zipes DP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005;45:1312-1375
12. Pelliccia A, Fagard R, Björnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the European Society of Cardiology. Eur Heart J 2005;26:1422-1455
13. Paterick TE, Paterick TJ, Fletcher GF, et al. Medical and legal issues impacting the cardiovascular evaluation of competitive athletes. JAMA 2005;294:3011-3018
14. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32:1881-1884 (Pubitemid 29010450)
15. Myerburg RJ, Vetter VL. Electrocardiograms should be included in preparticipation screening of athletes (editorial). Circulation 2007;116:2616-2626
16. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: Clinical, demographic and pathological profiles. JAMA 1996;276:199-204. (Pubitemid 26235063)
17. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-980
18. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1981-1989
19. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91:1596-1601
20. Rost R. The athlete's heart: historical perspective. In: Maron BJ, ed. Cardiology clinics, the athlete's heart. Philadelphia: WB Saunders, 1992:197-207.
21. Henschen S. Skilanglauf und skiwettlauf: eine medizinische sportstudie. Mitt Med Klin Upsala (Jena) 1899;2:15-18
22. Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med 1985;313:24-32.
23. Mitchell JH, Haskell W, Snell P, et al. Task Force 8: Classification of Sports. In: Maron BJ, Zipes DP, eds. 36th Bethesda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005;45:1364-1367
24. Morganroth J, Maron BJ, Henry WL, et al. Comparative left ventricular dimensions in trained athletes. Ann Intern Med 1975;82:521-524
25. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301.
26. Pelliccia A, Culasso F, Di Paolo F, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999;130:23-31. (Pubitemid 29019445)
27. Pelliccia A, Maron BJ, Culasso F, et al. Athlete's heart in women: echocardiographic characterization of highly trained elite female athletes. JAMA 1996;276:211-215 (Pubitemid 26235065)
28. Douglas PS, O'Toole ML, Katz SE, et al. Left ventricular hypertrophy in athletes. Am J Cardiol 1997;80:1384-1388
29. Abernethy WB, Choo JK, Hutter AM Jr. Echocardiographic characteristics of professional football players. J Am Coll Cardiol 2003;41:280-284 (Pubitemid 36092198)
30. Longhurst JC, Kelly AR, Gonyea WJ, et al. Chronic training with static and dynamic exercise: cardiovascular adaptation, and response to exercise. Circ Res 1981;48(suppl I):I-172-I-178.
31. Pluim BM, Zwinderman AH, van der Laarse A, et al. The athlete's heart: a metaanalysis of cardiac structure and function. Circulation 1999;100:336-344
32. Scharhag J, Schneider G, Urhausen A, et al. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002;410:1856-1863 (Pubitemid 35341966)
33. Milliken MC, Stray-Gundersen J, Peshock RM, et al. Left ventricular mass as determined by magnetic resonance imaging in male endurance athletes. Am J Cardiol 1988;62:301-305 (Pubitemid 18183475)
34. Fagard R, Aubert A, Lysens R, et al. Noninvasive assessment of seasonal variations in cardiac structure and function in cyclists. Circulation 1983;67:896-901. (Pubitemid 13161472)
35. Ehsani AA, Hagberg JM, Hickson RC. Rapid changes in left ventricular dimensions and mass in response to physical conditioning. Am J Cardiol 1978;42:52-56
36. Maron BJ, Pelliccia A, Spataro A, et al. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 1993;69:125-128 (Pubitemid 23056851)
37. Pelliccia A, Maron BJ, de Luca R, et al. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002;105:944-949 (Pubitemid 34184572)
38. Pelliccia A, Maron BJ, DiPaolo FM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005;46:690-696 (Pubitemid 41132699)
39. Martin WH III, Coyle EF, Bloomfield SA, et al. Effects of physical deconditioning after intense endurance training on left ventricular dimensions and stroke volume. J Am Coll Cardiol 1986;7:982-989
40. Sharma S, Maron BJ, Whyte G, et al. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete's heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1431-1436 (Pubitemid 35192868)
41. Cavallaro V, Petretta M, Betocchi S, et al. Effects of sustained training on left ventricular structure and function in top level rowers. Eur Heart J 1993;14:898-903. (Pubitemid 23238806)
42. Fagard R. Athlete's heart. Heart 2003;89:1455-1461
43. Longhurst JC, Kelly AR, Gonyea WJ, et al. Echocardiographic left ventricular masses in distance runners and weight lifters. J Appl Physiol 1980;48:154-162 (Pubitemid 10150857)
44. Pelliccia A, Spataro A, Caselli G, et al. Absence of left ventricular wall thickening in athletes participating in intense power training. Am J Cardiol 1993;72:1048-1054 (Pubitemid 23319929)
45. Hauser A, Dressendorfer RH, Vos M, et al. Symmetric cardiac enlargement in highly trained endurance athletes: a two-dimensional echocardiographic study. Am Heart J 1985;109:1038-1044 (Pubitemid 15053264)
46. Spirito P, Pelliccia A, Proschan MA, et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol 1994;74:802-806
47. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986;7:190-203.
48. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-284 (Pubitemid 30457576)
49. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 2008;51:2250-2255 (Pubitemid 351754997)
50. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;51:2256-2262 (Pubitemid 351754996)
51. Choo JK, Abernethy WB III, Hutter AM Jr. Electrocardiographic observations in professional football players. Am J Cardiol 2002;90:198-200.
52. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002;40:446-452 (Pubitemid 34833158)
53. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2004;44:1053-1058 (Pubitemid 39165141)
54. Biffi A, Maron BJ, Di Giacinto B, et al. Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes. Am J Cardiol 2008;101:1792-1795
55. Corrado D, Basso C, Rizzoli G, et al. Does sport activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42:1964-1966
56. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601 (Pubitemid 44515020)
57. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol 2008;51:1035-1039 (Pubitemid 351318133)
58. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320
59. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/ European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2003;42:1687-1713.
60. Lewis JA, Spirito P, Pelliccia A, et al. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing "athlete's heart" from hypertrophic cardiomyopathy. Br Heart J 1992;68:296-300.
61. Anastasakis A, Kotsiopoulou C, Rigopoulos A, et al. Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes. Heart 2005;91:1477-1478 (Pubitemid 41531834)
62. Vinereanu D, Florescu N, Schulthorpe N, et al. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001;88:53-58 (Pubitemid 32553892)
63. Sharma S, Elliott PM, Whyte G, et al. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 2000;36:364-370
64. Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-225 (Pubitemid 44297115)
65. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-861 (Pubitemid 41170072)
66. Maron BJ, Haas TS, Lesser JR. Diagnostic utility of cardiac magnetic resonance imaging in monozygotic twins with hypertrophic cardiomyopathy and identical pattern of left ventricular hypertrophy. Circulation 2007;115:e627-8.
67. MaronMS,Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited at 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:220-228
68. Maron MS, Appelbaum E, Harrigan C, et al. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008;1:184-191
69. Adabag AS, Kuskowski MA, Maron BJ. Determinants for clinical diagnosis of hypertrophic cardiomyopathy. Am J Cardiol 2006;98:1507-1511 (Pubitemid 44781428)
70. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2125-2132
71. Lewis JF, Maron BJ, Diggs JA, et al. Preparticipation echocardiographic screening for cardiovascular disease in a large predominantly black population of collegiate athletes. Am J Cardiol 1989;64:1029-1033
72. Maron BJ, Bodison S, Wesley Y, et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol 1987;10:1214-1221 (Pubitemid 18004671)
73. Pelliccia A, DiPaolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008;358:152-161
74. Maron BJ, Haas TS, Doerer JJ, et al. Comparison of US and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009;104:276-280
75. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: Update 2007. A Scientific Statement from the American Heart Association, Nutrition, Physical Activity, and Metabolism Council. Circulation 2007;115:1643-1645
76. Maron BJ, Mitten MJ, Quandt EK, et al. Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med 1998;339:1632-1635
77. Maron BJ, Spirito P, Shen W-K, et al. Implantable cardioverter- defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298:405-412
78. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and European Society of Cardiology Consensus Recommendations revisited: A Comparison of US and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008;52:1990-1996
79. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 1998;129:379-386
80. Mitten MJ, Maron BJ, Zipes DP. Task Force 12: Legal aspects of the 36th Bethesda Conference Recommendations. In 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities (Maron BJ, Zipes DP). J Am Coll Cardiol 2005;45:1373-1375